On the stock market since 1999, it operates in the world of money and finance. Now — the numbers.
This is an established company with proven profits.
No real growth (2% a year). Red columns mark years that ended in a loss.
Executives buying with their own money is usually read as confidence in the company’s future.
The stock trades 23% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 263% — still a thick cushion, though costs have been eating into it lately.
Over the last 12 months, company executives reported 4 buys and 2 sells. Management buying with its own money is usually read as a good sign.
It pays out $0.60 per share each year — regular cash for whoever holds the stock.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, GUT sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: GUT is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.